164 related articles for article (PubMed ID: 23392277)
1. Lupus-prone strains vary in susceptibility to antibody-mediated end organ disease.
Xie C; Du Y; Kumar K; Li L; Han J; Liu K; Zhou XJ; Mohan C
Genes Immun; 2013 Apr; 14(3):170-8. PubMed ID: 23392277
[TBL] [Abstract][Full Text] [Related]
2. Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain.
Xie C; Zhou XJ; Liu X; Mohan C
Arthritis Rheum; 2003 Apr; 48(4):1080-92. PubMed ID: 12687552
[TBL] [Abstract][Full Text] [Related]
3. Strain distribution pattern of immune nephritis--a follow-up study.
Xie C; Rahman ZS; Xie S; Zhu J; Du Y; Qin X; Zhou H; Zhou XJ; Mohan C
Int Immunol; 2008 Jun; 20(6):719-28. PubMed ID: 18381352
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of lupus-prone NZM mouse strains to lead exacerbation of systemic lupus erythematosus symptoms.
Hudson CA; Cao L; Kasten-Jolly J; Kirkwood JN; Lawrence DA
J Toxicol Environ Health A; 2003 May; 66(10):895-918. PubMed ID: 12825236
[TBL] [Abstract][Full Text] [Related]
5. Strain distribution pattern of susceptibility to immune-mediated nephritis.
Xie C; Sharma R; Wang H; Zhou XJ; Mohan C
J Immunol; 2004 Apr; 172(8):5047-55. PubMed ID: 15067087
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane.
Satoh M; Hamilton KJ; Ajmani AK; Dong X; Wang J; Kanwar YS; Reeves WH
J Immunol; 1996 Oct; 157(7):3200-6. PubMed ID: 8816434
[TBL] [Abstract][Full Text] [Related]
7. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization.
Rudofsky UH; Evans BD; Balaban SL; Mottironi VD; Gabrielsen AE
Lab Invest; 1993 Apr; 68(4):419-26. PubMed ID: 8479150
[TBL] [Abstract][Full Text] [Related]
8. The SLAM family member CD48 (Slamf2) protects lupus-prone mice from autoimmune nephritis.
Koh AE; Njoroge SW; Feliu M; Cook A; Selig MK; Latchman YE; Sharpe AH; Colvin RB; Paul E
J Autoimmun; 2011 Aug; 37(1):48-57. PubMed ID: 21561736
[TBL] [Abstract][Full Text] [Related]
9. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
[TBL] [Abstract][Full Text] [Related]
10. BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus.
Stohl W; Xu D; Kim KS; Koss MN; Jorgensen TN; Deocharan B; Metzger TE; Bixler SA; Hong YS; Ambrose CM; Mackay F; Morel L; Putterman C; Kotzin BL; Kalled SL
Arthritis Rheum; 2005 Jul; 52(7):2080-91. PubMed ID: 15986357
[TBL] [Abstract][Full Text] [Related]
11. Experimental anti-GBM disease as a tool for studying spontaneous lupus nephritis.
Fu Y; Du Y; Mohan C
Clin Immunol; 2007 Aug; 124(2):109-18. PubMed ID: 17640604
[TBL] [Abstract][Full Text] [Related]
12. Characterization of reactivity of monoclonal autoantibodies with renal antigens in experimental lupus nephritis.
Kootstra JC; Veninga A; Baelde JJ; van Eendenburg J; de Heer E; Bruijn JA
J Clin Lab Immunol; 1996; 48(5):201-18. PubMed ID: 9394243
[TBL] [Abstract][Full Text] [Related]
13. Experimental anti-GBM nephritis as an analytical tool for studying spontaneous lupus nephritis.
Du Y; Fu Y; Mohan C
Arch Immunol Ther Exp (Warsz); 2008; 56(1):31-40. PubMed ID: 18250969
[TBL] [Abstract][Full Text] [Related]
14. NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci.
Waters ST; Fu SM; Gaskin F; Deshmukh US; Sung SS; Kannapell CC; Tung KS; McEwen SB; McDuffie M
Clin Immunol; 2001 Sep; 100(3):372-83. PubMed ID: 11513551
[TBL] [Abstract][Full Text] [Related]
15. Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF.
Jacob CO; Pricop L; Putterman C; Koss MN; Liu Y; Kollaros M; Bixler SA; Ambrose CM; Scott ML; Stohl W
J Immunol; 2006 Aug; 177(4):2671-80. PubMed ID: 16888029
[TBL] [Abstract][Full Text] [Related]
16. Distinct mechanisms of action of anti-CD154 in early versus late treatment of murine lupus nephritis.
Quezada SA; Eckert M; Adeyi OA; Schned AR; Noelle RJ; Burns CM
Arthritis Rheum; 2003 Sep; 48(9):2541-54. PubMed ID: 13130474
[TBL] [Abstract][Full Text] [Related]
17. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis.
Kalaaji M; Sturfelt G; Mjelle JE; Nossent H; Rekvig OP
Arthritis Rheum; 2006 Mar; 54(3):914-26. PubMed ID: 16508974
[TBL] [Abstract][Full Text] [Related]
18. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
[TBL] [Abstract][Full Text] [Related]
19. Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans.
Liu K; Li QZ; Delgado-Vega AM; Abelson AK; Sánchez E; Kelly JA; Li L; Liu Y; Zhou J; Yan M; Ye Q; Liu S; Xie C; Zhou XJ; Chung SA; Pons-Estel B; Witte T; de Ramón E; Bae SC; Barizzone N; Sebastiani GD; Merrill JT; Gregersen PK; Gilkeson GG; Kimberly RP; Vyse TJ; Kim I; D'Alfonso S; Martin J; Harley JB; Criswell LA; ; ; ; ; ; ; Wakeland EK; Alarcón-Riquelme ME; Mohan C
J Clin Invest; 2009 Apr; 119(4):911-23. PubMed ID: 19307730
[TBL] [Abstract][Full Text] [Related]
20. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
Matsumoto K; Watanabe N; Akikusa B; Kurasawa K; Matsumura R; Saito Y; Iwamoto I; Saito T
Arthritis Rheum; 2003 Feb; 48(2):486-94. PubMed ID: 12571859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
